Ben from Germany

Registered at the short selling broker Skilling, 4 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

Abbott Laboratories (ABT) shares information

Abbott Laboratories


24h Change

-1.54 %

ABT

Live rate: Market closed

Stock data per Friday 23 Oct, 2020

ABT
New York Stock Exchange
109.48
109.64
107.79
-1.69 (-1.54%)
US Market is closed

Live Stock price in graph for Abbott Laboratories (ABT)

  • Latest Volume

    3,573,013 (-27.88 %)

  • Volume prev. day

    4,954,280

  • Avg. daily volume

    4,792,113

  • Market cap

    190,845,428,700

  • P/E ratio

    n/a

  • Today high

    110

  • Today low

    107.57

  • 52 week high

    114.2

  • 52 week low

    61.61

  • YTD Change

    + 22.42 %

Quick links

Broker recommendations for Abbott Laboratories

The Abbott Laboratories stock is rated at 1.357143 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Wednesday 9 September, 2020 by a total of 21 brokers. This means that the consensus of the 21 different brokers is leaning toward to buy/moderate buy.

Sell
1 (4.76%)
Underweight
1 (4.76%)
Hold
3 (14.29%)
Overweight
2 (9.52%)
Buy
14 (66.67%)

Price target by analysts

The 16 latest analyst estimates, per Thursday 22 October, 2020, show the following high, low and average price targets.
Target Average: 119.56 USD
Target High: 130 USD
Target Low: 99 USD

 

Latest news about Abbott Laboratories

Below you can find the most recent news posts about Abbott Laboratories, primarily from US and UK based news sources.

Latest News: Plausible Report on Cholesterol Medicines Market 2020-2027| Abbott Laboratories, Merck& Co, Bristol-Myers Squibb Company, AstraZeneca

Sunday, 25 October 2020, 15:26:54
To provide the global outlook of the Cholesterol Medicines Market a new statistical study has added by HealthCare Intelligence Markets to its massive database. During the analysis of this market the existing industries, as well as upcoming start-ups, have been
— OpenPR


Credit Suisse Group Lowers Abbott Laboratories (NYSE:ABT) Price Target to $118.00

Sunday, 25 October 2020, 10:10:47
Abbott Laboratories (NYSE:ABT) had its price target trimmed by Credit Suisse Group from $136.00 to $118.00 in a research report report published on Thursday, The Fly reports. The firm currently has an outperform rating on the healthcare product maker’s stock. A number of other research analysts also recently weighed in on the company. JPMorgan Chase […]
— Zolmax News


Abbott Laboratories (NYSE:ABT) Price Target Raised to $114.00

Sunday, 25 October 2020, 10:10:47
Abbott Laboratories (NYSE:ABT) had its price target boosted by Raymond James from $102.00 to $114.00 in a research note issued to investors on Thursday, Anlyst Ratings reports. The brokerage currently has an outperform rating on the healthcare product maker’s stock. Other research analysts have also recently issued research reports about the stock. Bank of America […]
— Zolmax News


Raymond James Increases Abbott Laboratories (NYSE:ABT) Price Target to $114.00

Sunday, 25 October 2020, 10:10:46
Abbott Laboratories (NYSE:ABT) had its target price boosted by Raymond James from $102.00 to $114.00 in a report published on Thursday, Anlyst Ratings reports. The firm currently has an outperform rating on the healthcare product maker’s stock. Other equities analysts also recently issued research reports about the stock. SVB Leerink upped their price objective on […]
— Dakota Financial News


Abbott Laboratories (NYSE:ABT) Expected to Post FY2020 Earnings of $3.55 Per Share

Sunday, 25 October 2020, 03:12:44
Abbott Laboratories (NYSE:ABT) – Investment analysts at William Blair raised their FY2020 earnings estimates for shares of Abbott Laboratories in a research report issued on Wednesday, October 21st. William Blair analyst M. Kaczor now anticipates that the healthcare product maker will post earnings per share of $3.55 for the year, up from their previous estimate […]
— Stock Observer


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €/$ 20
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have ABT available or trade one of the many other CFD stocks they have.
Risk warning: 75% of retail investor accounts lose money when trading CFDs with Capital.